University of Miami Miller School of Medicine
Founded as Florida’s first medical school in 1952. The 153-acre complex is shared by the School and Jackson Memorial Hospital and is known as the University of Miami / Jackson Memorial Medical Center. Research is a top priority; we rank in the top 3rd of U.S. medical schools in terms of research funding. The School’s commitment to community and culturalized medicine (a theme that continues today in our NIH Center for Translational Science Award) was recognized in 2001 with the first ever American Association of Medical Colleges’ Community Service Award.
In 2004, the School received an unrestricted $100 million gift from the Leonard Miller family and was formally designated as the Leonard M. Miller School of Medicine. Today, it is ranked fifth of all medical schools for Hispanic medical students. Pascal J. Goldschmidt, MD, was recruited from Duke University to lead the School in 2006. He has led a major renaissance of academic and clinical programs with the School’s annual operating budget more than doubling since his arrival to just over $2 billion. Laudable accomplishments include establishing the University’s Health System (UHealth), South Florida’s only comprehensive network of university-based patient care, anchored by the $350 million purchase of the University Hospital in 2007; and the $100 million Hussman Institute for Human Genomics. The Miller School and UHealth proudly serve Miami, South Florida, South America, and the Caribbean in its quaternary mission of education, research, patient care, and community partnership. Dean Goldschmidt’s strategic transformation of the School proved successful in advancing the University’s research achievements. The Miller School of Medicine climbed to No. 38 in National Institutes of Health funding in 2012, solidifying its position as the top NIH-funded medical school in Florida.
Engaging in more than 2,000 ongoing projects, Miller School researchers are making rapid progress at the bench and the bedside, working to better understand and eradicate devastating illnesses in the fields of HIV/AIDS, diabetes, cancer, cardiovascular disease, neurological disorders, substance abuse and vision. New tools and techniques in the disciplines of stem cell, genetics and data management empower researchers to move at unprecedented speed toward new methods of analysis and treatment.